Financial reports
10-K
2020 FY
Annual report
30 Sep 21
10-Q
2020 Q3
Quarterly report
24 May 21
10-Q
2020 Q2
Quarterly report
24 May 21
NT 10-K
Notice of late annual filing
14 Apr 21
NT 10-Q
Notice of late quarterly filing
14 Apr 21
NT 10-Q
Notice of late quarterly filing
14 Apr 21
10-Q
2020 Q1
Quarterly report
17 Jun 20
10-K/A
2019 FY
Annual report (amended)
15 May 20
10-K
2019 FY
Annual report
29 Apr 20
Current reports
8-K
Departure of Directors or Certain Officers
4 Jan 21
8-K
Results of Operations and Financial Condition
24 Nov 20
8-K
XG Sciences, Inc. Announces New Leadership
31 Aug 20
8-K
Results of Operations and Financial Condition
24 Jun 20
8-K
Results of Operations and Financial Condition
1 May 20
8-K
Entry into a Material Definitive Agreement
23 Apr 20
8-K
Other Events
30 Mar 20
8-K
Departure of Directors or Certain Officers
19 Mar 20
8-K
Departure of Directors or Certain Officers
14 Jan 20
8-K
Departure of Directors or Certain Officers
26 Mar 19
Registration and prospectus
15-15D
Suspension of duty to report
27 Jan 22
D
$10M in debt / options / securities to be acquired, sold $550K, 3 investors
6 May 20
POS AM
Prospectus update (post-effective amendment)
21 Jun 19
424B3
Prospectus supplement
27 Jun 18
POS AM
Prospectus update (post-effective amendment)
1 Jun 18
424B3
Prospectus supplement
27 Apr 17
POS AM
Prospectus update (post-effective amendment)
13 Apr 17
POS AM
Prospectus update (post-effective amendment)
13 Apr 17
424B3
Prospectus supplement
19 Jan 17
POS AM
Prospectus update (post-effective amendment)
10 Jan 17
Proxies
No filings
Other
EFFECT
Notice of effectiveness
25 Jun 19
EFFECT
Notice of effectiveness
27 Jun 18
CORRESP
Correspondence with SEC
18 Jun 18
UPLOAD
Letter from SEC
12 Jun 18
EFFECT
Notice of effectiveness
14 Apr 17
EFFECT
Notice of effectiveness
17 Jan 17
EFFECT
Notice of effectiveness
31 Aug 16
EFFECT
Notice of effectiveness
26 Aug 16
EFFECT
Notice of effectiveness
13 Apr 16
CORRESP
Correspondence with SEC
12 Apr 16